AGP Executive Report
Last update: 3 hours agoGLP-1 Safety Watch: Dermatologists are flagging “Ozempic Hair” as rapid weight loss from GLP-1 drugs can trigger temporary hair shedding, urging medically supervised use and balanced nutrition. Public Health Policy: WHO says ultra-processed food giants are suing governments to block obesity-fighting rules like warning labels and junk-food taxes, adding major legal and healthcare costs. Medication Recall: The FDA ordered a nationwide recall of Rohto Cooling Eye Drops due to lack of sterility assurance, warning consumers to check lot numbers and stop use if affected. Health Access: Tri-Area Community Health marked National Health Center Week, highlighting how community health centers deliver affordable primary care and wraparound services for millions. Retirement & Medicare Trap: A report warns that switching from Medicare Advantage back to Original Medicare can be blocked by underwriting for people with conditions like stents or GLP-1 prescriptions, especially after the Medigap guaranteed-issue window. Community Wellness: A Los Angeles benefit festival plans health screenings, food support, and mental health resources for thousands, with a “secret” location revealed shortly before the event. Fitness & Media Hype: Jillian Michaels warns against unregulated “gray-market” weight-loss peptides sold online, citing serious potential risks.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.